Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework

Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework

Podrobná bibliografie
Hlavní autoři:	Couillard, S, Pavord, I, Heaney, L, Petousi, N, Hinks, T
Médium:	Journal article
Jazyk:	English
Vydáno:	Wiley 2022

Podobné jednotky

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
Autor: Couillard, S, a další
Vydáno: (2021)

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
Autor: Couillard, S, a další
Vydáno: (2021)

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
Autor: Couillard, S, a další
Vydáno: (2022)

Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
Autor: Couillard, S, a další
Vydáno: (2020)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
Autor: Rastogi, S, a další
Vydáno: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
Autor: Moran, AM, a další
Vydáno: (2020)

Eosinophilic phenotypes of airway disease.
Autor: Pavord, I
Vydáno: (2013)

Prognostic value of using FeNO to guide step-down treatment decisions in asthma
Autor: Wang, K, a další
Vydáno: (2018)

Eosinophils in asthma and airway hyperresponsiveness.
Autor: Brightling, C, a další
Vydáno: (2004)

FeNO-based asthma management results in faster improvement of airway hyperresponsiveness
Autor: Katrine Feldballe Bernholm, a další
Vydáno: (2018-10-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
Autor: Connolly, CM, a další
Vydáno: (2017)

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
Autor: Couillard, S, a další
Vydáno: (2021)

Exhaled Nitric Oxide (FeNO) as a Non-Invasive Marker of Airway Inflammation
Autor: Mitsuru Munakata
Vydáno: (2012-01-01)

The Pitfalls of FeNO Testing
Autor: Sujoy Khan
Vydáno: (2013-01-01)

The Lancet COPD Commission: broader questions remain
Autor: Petousi, N, a další
Vydáno: (2023)

The significance of eosinophilic airway inflammation in asthma
Autor: Pavord, I, a další
Vydáno: (2002)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
Autor: Moran, A, a další
Vydáno: (2020)

Toward a predict and prevent approach in obstructive airway diseases
Autor: Couillard, S, a další
Vydáno: (2023)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
Autor: Brightling, C, a další
Vydáno: (2003)

The making of the atomic bomb /
Autor: 435392 Rhodes, Richard
Vydáno: (1986)

Prognostic value of FeNO-guided assessment to identify steroid-responsive respiratory symptoms
Autor: Wang, K, a další
Vydáno: (2018)

Association Between FeNO, Total Blood IgE, Peripheral Blood Eosinophil and Inflammatory Cytokines in Partly Controlled Asthma
Autor: Badar A, a další
Vydáno: (2020-10-01)

Current evidence and future research needs for FeNO measurement in respiratory diseases
Autor: Bjermer, L, a další
Vydáno: (2014)

Current evidence and future research needs for FeNO measurement in respiratory diseases.
Autor: Bjermer, L, a další
Vydáno: (2014)

Update on the Role of FeNO in Asthma Management
Autor: Neveda Murugesan, a další
Vydáno: (2023-04-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
Autor: Brightling, C, a další
Vydáno: (2000)

Association of general and abdominal obesity with lung function, FeNO, and blood eosinophils in adult asthmatics: Findings from NHANES 2007–2012
Autor: Haoyu Zhang, a další
Vydáno: (2023-02-01)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
Autor: Brightling, C, a další
Vydáno: (2004)

What is the added value of FeNO as T2 biomarker?
Autor: María Celeste Marcos, a další
Vydáno: (2022-08-01)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
Autor: Kulkarni, N, a další
Vydáno: (2010)

Exposure to organophosphate flame retardants and plasticizers is positively associated with wheeze and FeNO and eosinophil levels among school-aged children: The Hokkaido study
Autor: Yi Zeng, a další
Vydáno: (2023-11-01)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
Autor: Lavoie, G, a další
Vydáno: (2024)

Measuring lung function in airways diseases: current and emerging techniques
Autor: Petousi, N, a další
Vydáno: (2019)

Dark sun : the making of the hydrogen bomb /
Autor: 435392 Rhodes, Richard
Vydáno: (1995)

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease
Autor: Petousi, N, a další
Vydáno: (2024)

IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma
Autor: Jorge Sánchez, a další
Vydáno: (2021-03-01)

The change of FeNO is correlated with asthma control and lung function
Autor: Yanmin Gao, a další
Vydáno: (2024-10-01)

FeNO as a biomarker for airway inflammation due to exposure to air pollutants among school children nearby industrial areas in Terengganu
Autor: Kamaruddin, Anis Syafiqah, a další
Vydáno: (2019)

Blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO) for steroid stewardship in chronic obstructive pulmonary disorder (COPD): A systematic review
Autor: Aditi Dhawan, a další
Vydáno: (2024-09-01)

Nasal Airflow Measured by Rhinomanometry Correlates with FeNO in Children with Asthma.
Autor: I-Chen Chen, a další
Vydáno: (2016-01-01)